BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8957612)

  • 1. Improved detection of disseminated pheochromocytoma using post therapy I-131 MIBG scanning.
    Campbell L; Mouratidis B; Sullivan P
    Clin Nucl Med; 1996 Dec; 21(12):960-3. PubMed ID: 8957612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [131-iodine meta-iodobenzylguanidine scintigraphy and therapy in malignant pheochromocytoma].
    Kessel F; Hahn K; Eissner D; Beyer J; Thelen M
    Internist (Berl); 1986 Jan; 27(1):70-3. PubMed ID: 3514518
    [No Abstract]   [Full Text] [Related]  

  • 3. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
    Shulkin BL; Shen SW; Sisson JC; Shapiro B
    J Nucl Med; 1987 Mar; 28(3):315-8. PubMed ID: 3102702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone metastases in pheochromocytoma. Optimal timing of I-123 MIBG scintigraphy.
    Lau AK; Roach PJ
    Clin Nucl Med; 1996 Apr; 21(4):316-8. PubMed ID: 8925616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [131I-MIBG scintigraphy for the detection of metastatic lesions from malignant pheochromocytoma--comparison of 131I-MIBG scintigraphy with 99mTc-MDP bone scintigraphy in detecting bone metastases].
    Ozawa N; Imaeda T; Seki M; Koike S
    Kaku Igaku; 1988 Jan; 25(1):97-103. PubMed ID: 3373813
    [No Abstract]   [Full Text] [Related]  

  • 6. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
    Pujol P; Bringer J; Faurous P; Jaffiol C
    Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant paraganglioma of the mediastinum: a further diagnostic and therapeutic use of radiolabelled mIBG.
    Cornford EJ; Wastie ML; Morgan DA
    Br J Radiol; 1992 Jan; 65(769):75-8. PubMed ID: 1486373
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant pheochromocytoma. Diffuse skeletal metastases manifested by I-123-metaiodobenzylguanidine scintigraphy.
    Shields AT; Sandler Ed; Parisi MT; Hattner RS
    Clin Nucl Med; 1993 Feb; 18(2):166-7. PubMed ID: 8432070
    [No Abstract]   [Full Text] [Related]  

  • 9. Late presentation of metastatic pheochromocytoma: a problem case solved by I-131 MIBG scintigraphy.
    Geatti O; Shapiro B; Virgolini L
    Clin Nucl Med; 1990 Feb; 15(2):101-4. PubMed ID: 1690098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG.
    Nakabeppu Y; Nakajo M
    Ann Nucl Med; 1994 Nov; 8(4):259-68. PubMed ID: 7702971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 13. Extra-adrenal and metastatic pheochromocytoma: the role of 131I meta-iodobenzylguanidine (131I MIBG) in localization and management.
    Thompson NW; Allo MD; Shapiro B; Sisson JC; Beierwaltes W
    World J Surg; 1984 Aug; 8(4):605-11. PubMed ID: 6148810
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of m-[131I]iodobenzylguanidine in the treatment of malignant pheochromocytoma.
    Krempf M; Lumbroso J; Mornex R; Brendel AJ; Wemeau JL; Delisle MJ; Aubert B; Carpentier P; Fleury-Goyon MC; Gibold C
    J Clin Endocrinol Metab; 1991 Feb; 72(2):455-61. PubMed ID: 1991814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-iodobenzylguanidine in metastatic phaeochromocytoma.
    Stewart RJ; Anderson JR; Laird JD; Atkinson AB; Kennedy TL
    Clin Endocrinol (Oxf); 1984 Nov; 21(5):525-7. PubMed ID: 6499231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of 131-metaiodobenzylguanidine in the diagnosis and treatment of malignant pheochromocytomas].
    Carreño Hernández MC; Estrada J; Castejón J; Pérez Maestu R; Masa Vázquez C; de Letona JM
    Med Clin (Barc); 1986 Sep; 87(8):330-3. PubMed ID: 3773589
    [No Abstract]   [Full Text] [Related]  

  • 17. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-123 MIBG imaging and intraoperative localization of metastatic pheochromocytoma: a case report.
    Buhl T; Mortensen J; Kjaer A
    Clin Nucl Med; 2002 Mar; 27(3):183-5. PubMed ID: 11852305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nuclear medical therapy of pheochromocytoma].
    Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H
    Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.